IgA-nefropátia: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• BCMA 7
• CD19 8
• SGLT2 1
• CD20 0
• CD38 0
• IL-6 0
• JAK 0
• NLRP3 0
• TLR4 0
• mTOR 0
• STING 0
• IL-17 0
• AKT 0
• AMPK 0
• EGFR 0
• FAK 0
• GPX4 0
• HER2 0
• IL-1 0
• MET 0
• MYC 0
• NRF2 0
• PD-1 0
• PI3K 0
• STAT3 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-ERC

  Role of CD1c-reactive T cells and lipid antigens in post-streptococcal disease (CReativeLipid)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, Egyesült Királyság· EU contribution 1 491 316 EUR· until 2030. szept.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Antigen-specific treatments to target autoimmune kidney diseases (AUTO-TARGET)

  Universitaetsklinikum Hamburg-Eppendorf· Hamburg, Németország· EU contribution 1 499 663 EUR· until 2030. márc.

• European Commission (Horizon Europe) · HORIZON-RIA

  Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology (geneTIGA)

  Charite - Universitaetsmedizin Berlin· Berlin, Németország· EU contribution 6 393 734 EUR· until 2026. dec.· 8 countries

3 of 3 running projects, newest first. Listed amounts together: 9,4 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 14
• Gene Expression Profiling 14
• Proteomics 8
• Metabolomics 5
• Flow Cytometry 2
• Immunohistochemistry 4
• Magnetic Resonance Imaging 1
• Machine Learning 9
• Deep Learning 3
• Cohort Studies 14
• Genome-Wide Association Study 20

• Cross-phenotype integration of eQTL-based Mendelian randomization and transcriptomics prioritizes BMP2K in IgA vasculitis with nephritis.

  Front Immunol, 2026. szept.

• Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.

  Front Immunol, 2026. aug.

• Male reproductive surgeries and long-term kidney outcomes: a Mendelian randomization and meta-analysis of UK Biobank and FinnGen.

  Ren Fail, 2026. aug.

• The causal effect of juvenile idiopathic arthritis on IgA nephropathy: A Mendelian randomization study.

  Medicine (Baltimore), 2026. jún.

• Causal effect between chronic periodontitis and IgA nephropathy: Insights from a 2-sample bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. jún.

• Combination scRNA-seq with GWAS identifies genetic risk factors in IgA nephropathy: An observational study.

  Medicine (Baltimore), 2026. máj.

• Bidirectional Mendelian randomization study reveals no causal association between polycystic ovary syndrome and IgA nephropathy.

  Medicine (Baltimore), 2026. máj.

• Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization.

  PLoS Comput Biol, 2026. ápr.

• Comprehensive Analysis of IgA Nephropathy Causal Factors in Plasma Proteins, Immune Cell Types, and Immune Cell Traits.

  Clin J Am Soc Nephrol, 2026. márc.

• Genetic risk factors in rheumatoid arthritis: A Mendelian randomization study of chronic kidney disease in European populations.

  Medicine (Baltimore), 2025. okt.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.